Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome
- PMID: 2788176
- PMCID: PMC548934
- DOI: 10.1172/JCI114217
Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome
Abstract
To determine the possible mechanism(s) promoting alveolar fibrin deposition in the adult respiratory distress syndrome (ARDS), we investigated the initiation and regulation of both fibrinolysis and coagulation from patients with ARDS (n = 14), at risk for ARDS (n = 5), and with interstitial lung diseases (ILD) (n = 8), and normal healthy individuals (n = 13). Bronchoalveolar lavage (BAL) extrinsic pathway inhibitor activity was increased in ARDS BAL compared with patients at risk for ARDS (P = 0.0146) or normal controls (P = 0.0013) but tissue factor-factor VII procoagulant activity was significantly increased in ARDS BAL compared with all other groups (P less than 0.001). Fibrinolytic activity was not detectable in BAL of 10 of the 14 patients with ARDS and low levels of activity were found in BAL of the other four ARDS patients. Depressed fibrinolysis in ARDS BAL was not due to local insufficiency of plasminogen; rather, there was inhibition of both plasmin and plasminogen activator. Plasminogen activator inhibitor 1 was variably detected and low levels of plasminogen activator inhibitor 2 were found in two ARDS BAL samples, but plasminogen activator inhibitor 2 was otherwise undetectable. ARDS BAL antiplasmin activity was, in part, due to alpha 2-antiplasmin. We conclude that abnormalities that result in enhanced coagulation and depressed fibrinolysis, thereby predisposing to alveolar fibrin deposition, occur in the alveolar lining fluids from patients with ARDS.
Similar articles
-
Local abnormalities of coagulation and fibrinolytic pathways that promote alveolar fibrin deposition in the lungs of baboons with diffuse alveolar damage.J Clin Invest. 1989 Jul;84(1):181-93. doi: 10.1172/JCI114139. J Clin Invest. 1989. PMID: 2738151 Free PMC article.
-
Local abnormalities of coagulation and fibrinolysis and alveolar fibrin deposition in sheep with oleic acid-induced lung injury.Am Rev Respir Dis. 1988 Nov;138(5):1282-94. doi: 10.1164/ajrccm/138.5.1282. Am Rev Respir Dis. 1988. PMID: 3202484
-
Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome.Am J Physiol. 1991 Oct;261(4 Pt 1):L240-8. doi: 10.1152/ajplung.1991.261.4.L240. Am J Physiol. 1991. PMID: 1928357
-
Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.Crit Care Med. 2003 Apr;31(4 Suppl):S213-20. doi: 10.1097/01.CCM.0000057846.21303.AB. Crit Care Med. 2003. PMID: 12682443 Review.
-
The role of bronchoalveolar hemostasis in the pathogenesis of acute lung injury.Semin Thromb Hemost. 2008 Jul;34(5):475-84. doi: 10.1055/s-0028-1092878. Epub 2008 Oct 27. Semin Thromb Hemost. 2008. PMID: 18956288 Review.
Cited by
-
A comprehensive evaluation of early potential risk factors for disease aggravation in patients with COVID-19.Sci Rep. 2021 Apr 13;11(1):8062. doi: 10.1038/s41598-021-87413-6. Sci Rep. 2021. PMID: 33850192 Free PMC article.
-
The plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factor-dependent mechanism.Am J Pathol. 2004 Mar;164(3):1091-8. doi: 10.1016/S0002-9440(10)63196-3. Am J Pathol. 2004. PMID: 14982862 Free PMC article.
-
Enhanced expression of genes involved in coagulation and fibrinolysis in murine arthritis.Arthritis Res. 2000;2(6):504-12. doi: 10.1186/ar132. Epub 2000 Sep 20. Arthritis Res. 2000. PMID: 11056680 Free PMC article.
-
The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice.J Clin Invest. 2010 Jun;120(6):1950-60. doi: 10.1172/JCI38369. Epub 2010 May 24. J Clin Invest. 2010. PMID: 20501949 Free PMC article.
-
HEPBURN - investigating the efficacy and safety of nebulized heparin versus placebo in burn patients with inhalation trauma: study protocol for a multi-center randomized controlled trial.Trials. 2014 Mar 25;15:91. doi: 10.1186/1745-6215-15-91. Trials. 2014. PMID: 24661817 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources